The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | Unmet needs in LBCL: treatment options for elderly or frail patients
Paolo Strati, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the need to improve treatment options for elderly or frail patients with large B-cell lymphoma (LBCL) who cannot be treated with CAR-T therapy or bispecific antibodies, and comments on treatment combinations currently used in this patient population. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
